2011 · 45 citations · 0 references
LawHealth LawHealth PolicyHealth Care LawHealthcare LawPublic Health LawHealth Equity LawPatient-provider RelationshipsHealth Promotion LawPatient-clinician RelationshipRelational Care ModelsRelational Contract TheoryRelational Personhood
We carried out a phase II study on single oral administration of UFT in 17 patients with ovarian carcinoma. Two PR cases were observed out of 13 evaluable cases for a response rate was 15.4%. Side-effects, appearing in 10 of the cases (58.8%) were mainly anorexia (17.6%), stomatitis (17.8%), nausea/vomiting (11.8%), leukopenia (11.8%) and thrombocytopenia (11.8%), but they were not serious. UFT proved useful in the treatment of patients with ovarian carcinoma.